St Mary Medical Center is a clinical research site located in Langhorne, Pennsylvania, United States 19047.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
St Mary Medical Center has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Ischemic Stroke, Squamous Cell Non-small Cell Lung Cancer.
Sponsors: Celldex Therapeutics, Global Neurosciences Institute, Bristol-Myers Squibb.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
St Mary Medical Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St Mary Medical Center has 6 clinical trials on record, with 1 currently active. Their work covers Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Ischemic Stroke, Squamous Cell Non-small Cell Lung Cancer.
Yes — St Mary Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.